Research & Development

Novartis announced today that it has exercised an option to in-license ECF843 for ophthalmic indications worldwide (outside Europe). The closing...

Zambon S.p.A., an international pharmaceutical company strongly committed to the central nervous system (CNS) therapeutic area, and Valeo Pharma Inc.,...

  Sumitomo Dainippon Pharma Co., Ltd. announced that the Company has concluded a license agreement with Bukwang Pharmaceutical Co., Ltd....

Aurinia Pharmaceuticals Inc announced the outcome of discussions with both the EMA and the PMDA in Japan regarding the development...

IBM and Lipscomb University College of Pharmacy announced an initiative to help train the next-generation of pharmacists on business analytics...

Medigene had contracted Mitsui Norin since 2005 for manufacturing and supplying the active pharmaceutical ingredient (API) of Veregen®. Based on...

Recipharm, the contract development and manufacturing organisation (CDMO), has entered into a long term agreement with Sato Pharmaceutical Co. for...

BioSig Technologies, Inc , a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address an...

PMV Pharmaceuticals, Inc., a leader in the discovery and development of p53-targeted small molecule drugs for the treatment of cancer...

Vifor Pharma, a company of the Galenica Group, and ChemoCentryx, Inc. announced that Vifor Pharma has gained rights to commercialize...